These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 12829999)
21. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest. Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302 [TBL] [Abstract][Full Text] [Related]
22. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY; Tseng CC Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033 [TBL] [Abstract][Full Text] [Related]
23. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613 [TBL] [Abstract][Full Text] [Related]
24. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Gooch JL; Herrera RE; Yee D Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100 [TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539 [TBL] [Abstract][Full Text] [Related]
26. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Chen F; Chang D; Goh M; Klibanov SA; Ljungman M Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424 [TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291 [TBL] [Abstract][Full Text] [Related]
29. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441 [TBL] [Abstract][Full Text] [Related]
30. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665 [TBL] [Abstract][Full Text] [Related]
31. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981 [TBL] [Abstract][Full Text] [Related]
32. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912 [TBL] [Abstract][Full Text] [Related]
33. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Sato H; Ishihara S; Kawashima K; Moriyama N; Suetsugu H; Kazumori H; Okuyama T; Rumi MA; Fukuda R; Nagasue N; Kinoshita Y Br J Cancer; 2000 Nov; 83(10):1394-400. PubMed ID: 11044367 [TBL] [Abstract][Full Text] [Related]
34. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways. Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845 [TBL] [Abstract][Full Text] [Related]
35. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. Shen ZN; Nishida K; Doi H; Oohashi T; Hirohata S; Ozaki T; Yoshida A; Ninomiya Y; Inoue H Biochem Biophys Res Commun; 2005 Mar; 328(2):375-82. PubMed ID: 15694358 [TBL] [Abstract][Full Text] [Related]